(Q44972571)

7 December 2017

title

Separation and characterization of adjuvant oligosaccharide oleate ester derived from product mixture of mannitol-oleic acid esterification (English)

1 reference

7 December 2017

1 reference

Kenji Oda

1

1 reference

7 December 2017

Yukari Sato

2

1 reference

7 December 2017

Shigeji Katayama

3

1 reference

7 December 2017

Asao Ito

4

1 reference

7 December 2017

Toshiaki Ohgitani

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

22

1 reference

7 December 2017

issue

21-22

1 reference

7 December 2017

page(s)

2812-2821

1 reference

Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Adjuvant and antitumour activities of synthetic lipid A analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Antigen dependent adjuvant activity of a polydispersed β-(1,4)-linked acetylated mannan (acemannan)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Development of adjuvant-active nonionic block copolymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Adjuvant activity of incomplete Freund's adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Characterization of mannide monooleate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

A Cell Culture Assay to Evaluate the Toxicity of Arlacel A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Hexitol anhydrides; the structures of the anhydromannitols of Brigl and Grüner; the structure of isomannide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Metabolic Fate of Mineral Oil Adjuvants Using 14C-Labeled Tracers II: Mannide Monooleate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Relationship between adjuvant activity and amphipathic structure of soyasaponins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

13C nuclear magnetic resonance spectra and the tautomeric equilibria of ketohexoses in solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Adjuvants--a classification and review of their modes of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Lymphokine control of in vivo immunoglobulin isotype selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

Adjuvants designed for veterinary and human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.047

10.1016/J.VACCINE.2004.01.047

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference